DuRoss Amy 4

What Happened Amy DuRoss, a director of BioLife Solutions, was granted 8,170 restricted shares (reported as an Award/Grant, code A) on February 24, 2026. No purchase price or dollar value is reported (price = N/A). These shares were issued under the BioLife Solutions 2023 Performance Incentive Plan and are subject to vesting conditions in the footnote.

Key Details

• Transaction date: 2026-02-24; filing date: 2026-02-26 (appears timely — Form 4 filed within two business days).
• Transaction type: Award/Grant (A); shares granted: 8,170; reported price: N/A.
• Shares owned after transaction: Not specified in the filing.
• Vesting note: Per the filing, the restricted stock is granted under the 2023 Performance Incentive Plan and "fully vests on the first anniversary of the vesting date of January 2, 2026" (effectively vesting on or about Jan 2, 2027).
• No 10b5-1 plan, cashless exercise, or tax-withholding mechanics are disclosed in this filing.

Context Restricted stock grants to directors are commonly part of compensation and retention packages and do not represent an immediate market purchase or sale. Because these shares vest in the future, they do not indicate an immediate bullish or bearish trade by the insider; they reflect compensation tied to continued service and/or performance.